KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Return on Sales (2016 - 2026)

Ionis Pharmaceuticals (IONS) has disclosed Return on Sales for 18 consecutive years, with 0.38% as the latest value for Q1 2026.

  • For Q1 2026, Return on Sales rose 74.0% year-over-year to 0.38%; the TTM value through Mar 2026 reached 0.06%, up 6.0%, while the annual FY2025 figure was 0.0%, 1.0% down from the prior year.
  • Return on Sales hit 0.38% in Q1 2026 for Ionis Pharmaceuticals, down from 0.75% in the prior quarter.
  • Across five years, Return on Sales topped out at 1.57% in Q4 2024 and bottomed at 1.2% in Q1 2024.
  • Average Return on Sales over 5 years is 0.38%, with a median of 0.45% recorded in 2023.
  • Year-over-year, Return on Sales crashed -459bps in 2022 and then surged 160bps in 2024.
  • Ionis Pharmaceuticals' Return on Sales stood at 0.35% in 2022, then soared by 91bps to 0.03% in 2023, then skyrocketed by 5201bps to 1.57% in 2024, then crashed by -53bps to 0.75% in 2025, then tumbled by -150bps to 0.38% in 2026.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.38%, 0.75%, and 0.82% for Q1 2026, Q4 2025, and Q3 2025 respectively.